Feb 28, 2017 12:01 pm UTC| Business
Allowed patent application claims methods for generating radioimmunoconjugates linked to Actinium-225Patent expected to expire in July 2030 NEW YORK, Feb. 28, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM)...
Feb 28, 2017 12:01 pm UTC| Business
NEW HAMPTON, N.Y., Feb. 28, 2017 -- Balchem Corporation (NASDAQ:BCPC) today reported for the fourth quarter 2016 net earnings of $15.9 million, compared to net earnings of $15.7 million for the fourth quarter 2015....
Feb 28, 2017 12:01 pm UTC| Business
NEW HAMPTON, N.Y., Feb. 28, 2017 -- Balchem Corporation (NASDAQ:BCPC) today reported for the fourth quarter 2016 net earnings of $15.9 million, compared to net earnings of $15.7 million for the fourth quarter 2015....
Antares Pharma to Present at the Cowen and Company 37th Annual Healthcare Conference
Feb 28, 2017 12:01 pm UTC| Business
EWING, N.J., Feb. 28, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 37th Annual Healthcare Conference on...
Antares Pharma to Present at the Cowen and Company 37th Annual Healthcare Conference
Feb 28, 2017 12:01 pm UTC| Business
EWING, N.J., Feb. 28, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 37th Annual Healthcare Conference on...
Summit Therapeutics Recognises 10th Annual Rare Disease Day
Feb 28, 2017 12:00 pm UTC| Business
OXFORD, United Kingdom, Feb. 28, 2017 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and Clostridium difficile...
Feb 28, 2017 12:00 pm UTC| Business
SANTA MONICA, Calif., Feb. 28, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that the Company has...